Posters Friday 31 January

Posters Friday 31 January 

TOPIC: Outcome measure & Care

370 - LUMEN: A Large Language Model for Dementia Assessment through Conversational AI
Judith Harrison
416 - The Lewy body dementia domain rating scale (LBD-DRS): a roadmap for validation and adoption
Joseph Kane
68 - Exploring Knowledge, Awareness and Practice (KAP) of Lewy Body Dementia in Irish care home staff
Rachel Fitzpatrick
200 - Differences in mental health hospitalisations between Lewy body dementia and Alzheimer’s disease
Alison Killen
216 - Predictors of Death within 6 Months in Individuals with Dementia with Lewy Bodies
Melissa Armstrong
187 - What's missing in LBD quality of life assessment? The case for a new preference-based PROM
Irina Kinchin
43 - Creating a virtual Community of Practice for Lewy body dementia
Alison Killen
50 - Sex-Specific Reproductive Health Risk Factors in Lewy Body Dementia
Samantha Holden
301 - Test-retest reliability of computerised attentional tasks in prodromal Lewy body dementia
Jahfer Hasoon
456 - Models of Peer Support for Lewy-Body Dementia: A Systematic Scoping Review
Aoife O' Brien
483 - Optimizing Nursing Care for Patients with Lewy Body Dementia: A comprehensive Approach to Management and Support.
Alexandra Sourla
53 - Understanding personal experiences of diagnosis and care for Lewy Body Dementia in Ireland.
Jayne Conlon
71 - The high cost of care and limited evidence on cost-effective strategies for Lewy body dementia: systematic review of evidence
Irina Kinchin
72 - The EMERALD-Lewy research program: Improving the diagnosis, management, and lived experience of Lewy body dementia in Ireland
Iracema Leroi
98 - Keepsake Chronicles for Lewy Body Dementia: An arts-based intervention to value personhood
Iracema Leroi
253 - Feasibility and benefits of an online psychosocial group for family carers of people with Lewy body dementia
Rachel Thompson
264 - Is air pollution associated with physical activity and sleep parameters in participants with dementia with Lewy bodies?
Debby Tsuang
315 - Lewy body dementias research in Latin America: A scoping review
Salomón Salazar-Londoño
338 - A Matching Profile Tool and Computer-Driven Algorithm for Compatible Peer-to-Peer Caregiver Support
Angela Lunde
342 - Sociodemographic and clinical characteristics of a Lewy Body Disease population in a specialized Latin American center
Felipe Botero-Rodriguez
356 - The landscape of dementia with Lewy bodies research: A scoping review of approaches and topics related to the perspectives of those affected by the disease
Paula Sinead Donnelly
382 - Understanding LBD Speech: Towards an Adaptive Voice Assistant for Enhanced Communication
Yong Ma
378 - Long term cognitive outcome of prodromal and mild dementia with Lewy bodies: a cohort study
Frédéric Blanc
196 - Overview of Low- and Middle-Income Country Authorship for Dementia with Lewy Bodies Research
Annegret Habich
86 - From data to dialogue: an AI-assisted approach to setting research priorities for Lewy Body Dementia
Irina Kinchin

TOPIC: Therapeutics in DLB
95 - Neuromodulation for Cognitive Impairment in Lewy body-related cognitive impairment: Exploring Patient Acceptance
Ananya Sanagavaram
310 - Profiling of Aggregation-Prone Motifs in Alpha-Synuclein and Implication for Targeted Therapeutic Development
Sumedha Shah
419 - The efficacy of electroconvulsive therapy in patients with Lewy Body Diseases: A retrospective study
Matasaburo Kobayashi
76 - Occipital nerve stimulation for cognitive impairment in Parkinson's Disease - an open-label field study
Liam Kennedy
218 - Deep Brain Stimulation for Motor symptoms in patients with Parkinson’s disease DEmentia (DBS-MODE)
Vibuthi Sisodia
250 - User satisfaction with digitalization and development of new exploratory digital biomarkers in a clinical drug trial testing Ambroxol in Dementia with Lewybodies
Jessica Hubbers
314 - The ANeED Study: Challenges in Recruiting Lewy Body Patients for a Clinical Trial
Regine Strand
316 - Compound Screening for Alpha-Synuclein Directed Small Molecules
Nwenite-Walter Osedeme
334 - Patient and Public Involvement and Engagement (PPIE) in the COBALT* trial - Motivation and Experiences of members *Combining memantine and cholinesterase inhibitors in Lewy body dementia treatment trial
Alison Killen
335 - Addressing the distinctive needs of people with Lewy Body Dementia and their families: the lived experiences of the COBALT* clinical trial patient and public involvement and engagement (PPIE) group. *Combining memantine And cholinesterase inhibitors in Lewy body dementia Treatment).
Alison Killen
386 - Gamified Data Collection for Lewy Body Dementia: A Smart, Non-Obtrusive Approach to Longitudinal Monitoring and Insight Discovery
Mahya Jahanshahikhabisi
440 - COmBining memantine And cholinesterase inhibitors in Lewy body dementia Treatment (COBALT)
Sarah Dunn
450 - Eligibility Criteria of Previous Randomized Clinical Trials in Patients with Dementia with Lewy Bodies
Juliette Alphen
207 - ANeED Study - Ambroxol in New and Early Dementia with Lewybodies Study - a status update on recruitment, safety, and tolerability
Rongve Arvid

Outcome measure & Care
73 - Developing an integrated care pathway (ICP) for Lewy Body Disease in Ireland
Aofie O'Brien